Group One Trading
ARMP icon

Group One Trading’s Armata Pharmaceuticals ARMP Stock Holding History

Group One Trading’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,600
Closed -$2.96K – 7551
2024
Q4 		$2.96K Hold
1,600
– – ﹤0.01% 6614
2024
Q3 		$3.79K Buy
+1,600
New +$4.09K ﹤0.01% 5980

Other funds holding ARMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Group One Trading's ARMP Position: Q4 2025 in Review

Group One Trading sold out of Armata Pharmaceuticals (ARMP) in Q4 2025, closing a stake of 3,000 shares — an estimated $8.94K sold.

Group One Trading first reported a position in ARMP in Q3 2024 and held it in 5 quarters. The position peaked at $48.1K in Q3 2024. 36 funds tracked by Wall St. Rank hold ARMP as of Q4 2025.

  • Group One Trading reported no remaining Armata Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 3,000 Armata Pharmaceuticals shares in Q4 2025, an estimated $8.94K.
  • Group One Trading first reported a position in Armata Pharmaceuticals in Q3 2024 and held it in 5 quarters.
  • Group One Trading's Armata Pharmaceuticals position peaked at $48.1K in Q3 2024.
  • 36 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.